Drugs / AV2-DM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01654822 | Aug → Dec 2012 | anogenital human papillomavirus infection | Cesa Projects International | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AV2-DM | “AV2-DM is an effective antiviral in reducing on short term (3 months) the human papillomavirus (HPV) infection.” NCT01654822 ↗ |
| Route | Topical | “one time (2 puffs) topical application of 100µl AV2-DM antiviral spray( containing 50% AV2-DM and 50% olive oil)on the cervix” NCT01654822 ↗ |